Several leading firms worldwide focus on the manufacture of complex medicinal APIs, notably Abacavir Sodium sulfate, Abarelix, and Abiraterone Mesylate. These compounds present significant hurdles in process building due to their molecular intricacy. The suppliers of these APIs often employ advanced technologies and adhere to strict regulatory guid